3 Defendants Oppose MDL For Onglyza Diabetes Drug Federal Lawsuits

Mealey's (November 10, 2017, 1:27 PM EST) -- WASHINGTON, D.C. — The three defendants in a proposed Onglyza/Kombiglyze multidistrict litigation on Nov. 2 told a federal judicial panel that it should deny centralization because there are fewer than 40...
To view the full article, register now.